X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
accord copd (9) 9
chronic obstructive pulmonary disease (8) 8
humans (8) 8
efficacy (7) 7
index medicus (7) 7
pulmonary disease, chronic obstructive - drug therapy (7) 7
safety (7) 7
aclidinium bromide (6) 6
lung diseases, obstructive (6) 6
respiratory system (6) 6
tiotropium (6) 6
treatment outcome (6) 6
lung - drug effects (5) 5
muscarinic antagonists - administration & dosage (5) 5
muscarinic antagonists - adverse effects (5) 5
obstructive pulmonary-disease (5) 5
tropanes - administration & dosage (5) 5
tropanes - adverse effects (5) 5
aclidinium (4) 4
acting muscarinic antagonist (4) 4
administered twice (4) 4
bronchodilator agents - administration & dosage (4) 4
bronchodilator agents - adverse effects (4) 4
copd patients (4) 4
drug therapy (4) 4
lung - physiopathology (4) 4
pulmonary disease, chronic obstructive - physiopathology (4) 4
recovery of function (4) 4
time factors (4) 4
administration, inhalation (3) 3
aged (3) 3
anticholinergic (3) 3
bromide (3) 3
bronchodilator agents - therapeutic use (3) 3
copd (3) 3
drug administration schedule (3) 3
dry powder inhalers (3) 3
female (3) 3
male (3) 3
middle aged (3) 3
muscarinic antagonists - therapeutic use (3) 3
placebo (3) 3
pulmonary disease, chronic obstructive - diagnosis (3) 3
respiratory agents (3) 3
review (3) 3
tropanes - therapeutic use (3) 3
adrenergic beta-2 receptor agonists - administration & dosage (2) 2
bronchodilation (2) 2
bronchodilators (2) 2
care and treatment (2) 2
development and progression (2) 2
disease progression (2) 2
diseases of the respiratory system (2) 2
dosage and administration (2) 2
dose-response relationship, drug (2) 2
dyspnea (2) 2
dyspnea - drug therapy (2) 2
fixed-dose combinations (2) 2
forced expiratory volume (2) 2
formoterol (2) 2
formoterol fumarate (2) 2
formoterol fumarate - administration & dosage (2) 2
hyperinflation (2) 2
international journal of chronic obstructive pulmonary disease (2) 2
laboratories (2) 2
long-acting muscarinic antagonist (2) 2
long-term safety (2) 2
medical research (2) 2
medicine, experimental (2) 2
medicine, general & internal (2) 2
moderate (2) 2
multidose dry powder inhaler (2) 2
patient outcomes (2) 2
patient-reported outcomes (2) 2
pharmacokinetics (2) 2
pharmacology & pharmacy (2) 2
quality of life (2) 2
quality-of-life (2) 2
research (2) 2
respiratory tract diseases (2) 2
severity of illness index (2) 2
studies (2) 2
1506 (1) 1
1867 (1) 1
400 mu-g (1) 1
accord (1) 1
accord copd i (1) 1
adherence (1) 1
adrenergic beta-2 receptor agonists - adverse effects (1) 1
adrenergic beta-2 receptor agonists - therapeutic use (1) 1
african americans (1) 1
age (1) 1
airway-obstruction (1) 1
animals (1) 1
antimuscarinic (1) 1
association (1) 1
attain (1) 1
australia (1) 1
bias (1) 1
bromide administered twice (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Respiratory research, ISSN 1465-9921, 2014, Volume 15, Issue 1, pp. 123 - 123
Background: Combining two long-acting bronchodilators with complementary mechanisms of action may provide treatment benefits to patients with chronic... 
Formoterol | Dyspnea | Health status | Lung function | Aclidinium | COPD | MODERATE | HYPERINFLATION | BRONCHODILATION | MAINTENANCE | OBSTRUCTIVE PULMONARY-DISEASE | RESPIRATORY SYSTEM | TIOTROPIUM | BROMIDE | ACCORD COPD | FLUTICASONE | Bronchodilator Agents - administration & dosage | Humans | Middle Aged | Muscarinic Antagonists - adverse effects | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | North America | Recovery of Function | Forced Expiratory Volume | Time Factors | Adrenergic beta-2 Receptor Agonists - adverse effects | Female | Bronchodilator Agents - adverse effects | Tropanes - administration & dosage | Pulmonary Disease, Chronic Obstructive - diagnosis | Tropanes - adverse effects | Dry Powder Inhalers | Double-Blind Method | Drug Administration Schedule | Formoterol Fumarate - adverse effects | Administration, Inhalation | Treatment Outcome | Dyspnea - physiopathology | Lung - physiopathology | New Zealand | Muscarinic Antagonists - administration & dosage | Lung - drug effects | Adrenergic beta-2 Receptor Agonists - administration & dosage | Dyspnea - drug therapy | Aged | Australia | Health Status | Drug Combinations | Formoterol Fumarate - administration & dosage | Pulmonary Disease, Chronic Obstructive - drug therapy | Medicine, Experimental | Pharmaceutical industry | Medical research | Studies | Heart attacks | Laboratories | Smooth muscle | Chronic obstructive pulmonary disease | Drug therapy | Research
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Expert Opinion on Drug Discovery, ISSN 1746-0441, 06/2018, Volume 13, Issue 6, pp. 563 - 577
Journal Article
BMJ Open Diabetes Research & Care, ISSN 2052-4897, 04/2016, Volume 4, Issue 1, p. e000160
ObjectiveHypoglycemia is a serious complication of diabetes treatment. This retrospective observational study characterized hypoglycemia-related hospital... 
MORTALITY | EVENTS | EPIDEMIOLOGIC ANALYSIS | ENDOCRINOLOGY & METABOLISM | ACCORD | DEATH | TYPE-2 | ASSOCIATION | Coma | Emotional disorders | Laboratories | Bias | Mortality | Health care policy | African Americans | Emergency medical care | Hypoglycemia | Data bases | Studies | Variables | Health Insurance Portability & Accountability Act 1996-US | Hospitals | Socioeconomic factors | Race | Health care access | Diabetes | Age | Dementia
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.